Takeda Hits Lupin With IP Suit Over Acid Reflux Drug

Law360, New York (November 30, 2012, 5:06 PM EST) -- Takeda Pharmaceutical Co. Ltd. on Thursday accused generic-drug maker Lupin Ltd. and a U.S. subsidiary of infringing four of its patents in a suit New Jersey that marks the company's latest attempt to protect the acid reflux drug Prevacid.

Osaka, Japan-based Takeda and three of its U.S. units claim in New Jersey federal court that Lupin has asked the U.S. Food and Drug Administration for approval of a version of the drug generically known as lansoprazole, despite being aware that the application infringed Takeda’s patents for...
To view the full article, register now.